Sign In
Last checked at 
5 Mar 2018 14:55
Share buy-back week 9/2018
Share buy-back week 9/2018
Announcement 5 March 2018
Coloplast – transactions in connection with share buy-back programme
As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to take place from 26 February, 2018 to 25 August, 2018.
The buy-back programme will be structured in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Regulation 2016/1052, also referred to as the "Safe Harbour" rules, which ensure that the company is protected against violation of insider legislation in connection with the buyback programme.
The following transactions have been executed during the period 26 February – 2 March 2018:
| Date | Number of shares | Buying price | Amount DKK |
| 26 February 2018 | 17,141 | 528.57 | 9,060,190.94 |
| 27 February 2018 | 10,070 | 522.58 | 5,262,405.78 |
| 28 February 2018 | 6,840 | 518.36 | 3,545,614.55 |
| 1 March 2018 | 15,153 | 511.33 | 7,748,180.46 |
| 2 March 2018 | 19,938 | 507.57 | 10,119,850.91 |
| Accumulated until now under the programme | 69,142 | 516.85 | 35,736,242.64 |
Henceforth, Coloplast owns 3,619,870 treasury B shares of DKK 1 equal to 1.68% of the company’s total share capital.
An overview showing the transaction data for the period 26 February to 2 March is enclosed.
Kind regards,Investor RelationsColoplast A/STel. +45 4911 1800
For further information, please contact
Investors and analysts
Ellen BjurgertDirector, Investor RelationsTel. +45 4911 1800/+45 4911 3376Email: dkebj@coloplast.com
Rasmus SørensenSr. Manager, Investor RelationsTel. +45 4911 1800/ +45 4911 1786Email: dkraso@coloplast.com Press and the media
Lina DanstrupSr. Media Relations ManagerTel. 4911 2607Email: dklina@coloplast.com
This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ about 11,000 people.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2018-03 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.
05032018_Sharebuyback
Transaction data_week9
© 2018 GlobeNewswire, Inc. All rights reserved.
Follow the stocks
